Brief: Bone Biologics Got Letter From Nasdaq Confirming Decision Of Panel That Co Currently Shows Compliance With Continued Listing Requirements
05/07/2023 22:34
July 5 (Reuters) - Bone Biologics Corp BBLG.O :
* BONE BIOLOGICS :ON JUNE 28, GOT LETTER FROM NASDAQ
CONFIRMING
DECISION OF PANEL THAT CO CURRENTLY SHOWS COMPLIANCE WITH
CONTINUED LISTING REQUIREMENTS
Source text for Eikon: ID:
Further company coverage: BBLG.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bone Biologics
See all newsBone Biologics Corp expected to post a loss of 39 cents a share - Earnings Preview
Brief: Bone Biologics Extends Rhnell-1 Shelf Life To 24 Months
Brief: Bone Biologics CEO Issues Letter To Stockholders Highlighting Company Update And Outlook
Bone Biologics Corp expected to post a loss of 53 cents a share - Earnings Preview
Bone Biologics Corp expected to post a loss of 58 cents a share - Earnings Preview